2-2.5 years
Initial protection for 5 years. It can be renewed 4 times, each time for 5 years, with a maximum protection of 25 years. If the design is part of a complex product and is used to restore the integrity of the product, it is valid for a maximum of 15 years from the filing date.
- Grant fee: The applicant shall pay the granted announcement fee within 2 months after receiving the official notification.
- Annuity: The annual fee can be paid once every 5 years, and the annual fee can be paid within a grace period of 6 months if the annual fee is overdue, and a 20% penalty should be paid at the same time.
5 months
Filing Language: English/Finnish
via Paris Convention via Nationalization of PCT Necessary documents:
- Abstract
- Abstract Drawing
- Claim
- Specification
- Drawing
Necessary documents:
- Abstract
- Abstract Drawing
- Claim
- Specification
- Drawing
Attachments (if any)
- Power of Attorney
- Scanned Copy of Certified Priority Document / DAS
- Declaration of Ownership/Certification of Employment/Assignment of priority
- Assignment for Patent Right Transfer
- Notification issued by CNIPA notify the applicant the application has passed through the security review
Attachments (if any)
- WIPO Publication
- ISR/IPRP
- Entry into the Finnish national phase 19/28/34/41 amended
- Power of Attorney
- Declaration of Ownership/Certification of Employment/Assignment of priority
- Assignment for Patent Right Transfer
yes
The novelty grace period is 12 months before the filing date/priority date.
- via Paris Convention : 12 months from earliest priority date.
- via Nationalization of PCT : 31 months from earliest priority date.
- Validation of European Patent in EPO member states: 3 months from the date of European patent grant
The novelty of the invention will not be lost if the information about the invention is disclosed within 6 months before the filing date or the priority date if the following conditions are met:
- Disclosure due to apparent misuse by the applicant or its predecessor owners
- The invention is disclosed at an official or officially recognized international exhibition
Reinstatement of priority is accepted on the grounds of "due care".
Reinstatement of priority is accepted on the grounds of "due care".